A calutron in Dallas hit 15.38% U-235. The step it might delete matters more.

The accreditation covers the ruler, not the run. Actinide says an ISO/IEC 17025-accredited laboratory measured the sample independently ^[2], which is worth having, because it means the 15.38% figure was not self-graded. It certifies nothing about how the material reached that assay, and the company's separate claim to be the first startup to enrich natural uranium into HALEU has not been independently established ^[19]. The report also carries no mass for the batch ^[16]. Without kilograms, the result cannot be placed on the same axis as anything else in the fuel chain, and that axis is where the whole argument lives.

Against what the NRC actually licenses, the assay is high. Louisiana Energy Services is listed as licensed to enrich to 5.5% ^[11], and 15.38% is roughly 2.8 times that level ^[17]. The licence is the more instructive half of the comparison. LES holds one for production; Actinide's batch exists under a laboratory-scale exclusion in the federal regulations, and the company is not a commercial fuel supplier [c8a]. That exclusion is the legal category built to let exactly this kind of work happen without a production licence.

Demand is not the soft spot. The Department of Energy says HALEU remains unavailable from domestic suppliers at the scale commercial deployment requires ^[9], and the NRC's HALEU band runs from 5% to 20% U-235 ^[3], so a research batch at 15.38% is squarely the material reactor developers say they are short of.

The timeline is worth reading as two clocks. Robert Mendelsohn spent seven years researching and prototyping the separation technology before he and Eric Olszewski incorporated Actinide in September 2025 ^[12]. Olszewski says he financed the work before the company existed, moved his family to Dallas in early 2024, and put more than $1 million of his own money into it ^[13]. The seed round, led by Onto Ventures with Neo Ventures, Mana Ventures, Discipulus Ventures, Shor Capital and angel investors, closed in March 2026 ^[14], about six months after incorporation ^[18]. Long prototyping, short industrial record, and institutional money that is younger than most of the engineering.

That gap explains the product framing. Actinide positions Endurance as a general-purpose separator for isotopes used in nuclear energy, medicine, quantum systems and electronics ^[15]. Selling materials that need no fuel licence is a credible way to fund the years of work that a fuel licence takes. It also means the fuel claim gets validated last, because it is the line with the least revenue attached and the most regulators watching. Actinide's own framing concedes the point: its distinction rests on startup status, the laboratory-scale regulatory basis and the electromagnetic process, not on being the first American organisation to make HALEU ^[20].

The figure that would settle this is kilograms per month from one Endurance, at 15% or better, at a purity a fabricator will accept, under something other than an exclusion. Until that exists, what happened in Texas is a well-measured small batch of the right material, produced by a route that would skip a step the country has not built.